Related articles

Malnutrition is a common yet often overlooked concern in cancer care. Even when patients appear to be consuming adequate calories, they may continue to lose weight, experience fatigue, and suffer from a weakened immune system. A major underlying factor in these issues is metabolic imbalance.

Ivermectin, a well-known anti-parasitic drug, has recently garnered attention for its potential role in cancer adjunctive therapy. While its primary use is for treating parasitic infections, studies suggest that Ivermectin might play unexpected roles in inhibiting cancer cell growth, enhancing treatment efficacy, and supporting the immune system.

In cancer care, nutrition plays a crucial role. However, despite supplementing with various nutrients, many patients find little improvement in their condition. One commonly overlooked reason is malabsorption—the body’s inability to effectively absorb nutrients from food or supplements.

In the realm of cancer care, Poly-MVA, a nutritional supplement, is gaining attention for its potential role in supporting cellular energy metabolism and antioxidant systems. This unique formula combines Alpha-Lipoic Acid, B vitamins, minerals, and the Lipoic Acid Palladium Complex (LAPd), which are designed to assist the body’s recovery and healing processes during or after cancer treatment.

In recent years, the role of the gut microbiome in cancer care has gained increasing attention. Scientific studies have shown that the balance of intestinal bacteria plays a significant role in modulating the immune system, influencing not only cancer progression but also responses to treatment and overall recovery. Among various metabolites produced by gut bacteria, butyrate, a short-chain fatty acid (SCFA), stands out for its ability to support immune regulation and reduce inflammation in a gentle, natural way.